These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791 [TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling. Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976 [TBL] [Abstract][Full Text] [Related]
6. SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Lu DY; Tang CH; Yeh WL; Wong KL; Lin CP; Chen YH; Lai CH; Chen YF; Leung YM; Fu WM Eur J Pharmacol; 2009 Jun; 613(1-3):146-54. PubMed ID: 19285061 [TBL] [Abstract][Full Text] [Related]
7. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice. Marques FZ; Nelson E; Chu PY; Horlock D; Fiedler A; Ziemann M; Tan JK; Kuruppu S; Rajapakse NW; El-Osta A; Mackay CR; Kaye DM Circulation; 2017 Mar; 135(10):964-977. PubMed ID: 27927713 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Young MJ Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):174-80. PubMed ID: 18277151 [TBL] [Abstract][Full Text] [Related]
9. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function. Gao S; Long CL; Wang RH; Wang H Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734 [TBL] [Abstract][Full Text] [Related]
10. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097 [TBL] [Abstract][Full Text] [Related]
11. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity. Tan Y; Du J; Cai S; Li X; Ma W; Guo Z; Chen H; Huang Z; Xiao J; Cai L; Cai S Exp Hematol; 2006 Nov; 34(11):1553-62. PubMed ID: 17046575 [TBL] [Abstract][Full Text] [Related]
12. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964 [TBL] [Abstract][Full Text] [Related]
13. Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease. Jeewandara TM; Ameer OZ; Boyd R; Wyse BF; Underwood CF; Phillips JK Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):353-60. PubMed ID: 25676668 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis. Shiba Y; Takahashi M; Hata T; Murayama H; Morimoto H; Ise H; Nagasawa T; Ikeda U Cardiovasc Res; 2009 Jan; 81(1):169-77. PubMed ID: 18791205 [TBL] [Abstract][Full Text] [Related]
15. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859 [TBL] [Abstract][Full Text] [Related]